Please login to the form below
Zalviso
This page shows the latest Zalviso news and features for those working in and with pharma, biotech and healthcare.
Grunenthal and AcelRx’s Zalviso approved in EU
Grunenthal and AcelRx’ s Zalviso approved in EU. Provides new treatment for post-operative pain. ... delivery. AcelRx developed Zalviso and entered into a commercial collaboration with Grunenthal at the end of 2013.
Latest news
-
Shire and Baxalta drugs among CHMP's latest recommendations
Grunenthal's Zalviso (sufentanil) for the treatment of post-operative pain. A hybrid medicine, Zalviso's application relied in part on the results of studies carried out with a reference product
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
Grünenthal's relentless pursuit of relief
It is our passion to help these patients.”. It is also investing in New Technical Entities (NTEs) which include new formulations and devices, acquiring Zalviso, a combination of a medical device
-
Pharma deals in September 2015
PDL BioPharma is buying out the majority of the expected royalty stream from EU sales of AcelRX's phase III product, Zalviso for $65m. ... Royalty monetisation. 110. AcelRx Pharmaceuticals. PDL BioPharma. Zalviso sub-lingual formulation of sufentanil.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Account Manager – Med Comms – London
-
Salary TBC
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Project Manager, Medical Communications, Oxford
-
Excellent Salary
- Project Manager, Medical Communications, London
-
Excellent Salary
-
Senior Medical Writer
-
Great salary and benefits
- Group Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Medical Writer, e-learning/ training, London
-
Excellent Salary
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
-
Senior Medical Writer
-
Great salary and bebefits
-
Senior Programme Executive
-
Salary TBC
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
-
Scientific Director
-
Great salary and bebefits
Subscribe to our email news alerts
No results were found
- P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit
- Publicis LifeBrands Team win UK young Cannes Lions competition
- Sobi poaches Pfizer’s Fredrick Wetterlundh
- Rigel and Ultragenyx claim approvals for rare drugs
- VCCP Health strengthens client service team
- Is agile working benefiting the employee or the organisation?
PMHub
Ashfield
Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...
Latest intelligence
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
- Unique forum will unite NHS and industry to drive innovation
- HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...
Quick links
Infographics
